{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:46Z","timestamp":1753891966556,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Severe hyperlipidemia is characterized by markedly elevated blood triglyceride levels and severe early-onset cardiovascular diseases, pancreatitis, pancreatic necrosis or persistent multiple organ failure if left untreated. It is a rare autosomal recessive metabolic disorder originated from the variants of lipoprotein lipase gene, and previous studies have demonstrated that most cases with severe hyperlipidemia are closely related to the variants of some key genes for lipolysis, such as <jats:italic>LPL, APOC2, APOA5, LMF1<\/jats:italic>, and <jats:italic>GPIHBP1<\/jats:italic>. Meanwhile, other unidentified causes also exist and are equally worthy of attention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The 29-day-old infant was diagnosed with severe hyperlipidemia, registering a plasma triglyceride level as high as 25.46 mmol\/L. Whole exome sequencing was conducted to explore the possible pathogenic gene variants for this patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The infant was put on a low-fat diet combined with pharmacological therapy, which was successful in restraining the level of serum triglyceride and total cholesterol to a low to medium range during the follow-ups. The patient was found to be a rare novel homozygous duplication variant-c.45_48dupGCGG (Pro17Alafs<jats:sup>*<\/jats:sup>22) in <jats:italic>GPIHBP1<\/jats:italic> gene-leading to a frameshift which failed to form the canonical termination codon TGA. The mutant messenger RNA should presumably produce a peptide consisting of 16 amino acids at the N-terminus, with 21 novel amino acids on the heels of the wild-type protein.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study expands on the spectrum of <jats:italic>GPIHBP1<\/jats:italic> variants and contributes to a more comprehensive understanding of the genetic diagnosis, genetic counseling, and multimodality therapy of families with severe hyperlipidemia. Our experience gained in this study is also contributory to a deeper insight into severe hyperlipidemia and highlights the importance of molecular genetic tests.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.792574","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:00:25Z","timestamp":1646913625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Successful Management of a 29-Day-Old Infant With Severe Hyperlipidemia From a Novel Homozygous Variant of GPIHBP1 Gene"],"prefix":"10.3389","volume":"10","author":[{"given":"Shu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haimei","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/trf.16214","article-title":"Retrospective analysis of outcomes in patients with acute hypertriglyceridemic pancreatitis treated without therapeutic plasma exchange","volume":"61","author":"Hutchison","year":"2021","journal-title":"Transfusion."},{"key":"B2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/nu5030981","article-title":"Hypertriglyceridemia","volume":"5","author":"Brahm","year":"2013","journal-title":"Nutrients."},{"key":"B3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4158\/EP-2018-0157","article-title":"Familial chylomicronemia syndrome: a clinical guide for endocrinologists","volume":"24","author":"Falko","year":"2018","journal-title":"Endocr Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.10702","article-title":"Diagnosis and management of type I and type V hyperlipoproteinemia","volume":"19","author":"Gotoda","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"B5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/biof.1570","article-title":"A novel variant in LPL gene is associated with familial combined hyperlipidemia","volume":"46","author":"Taghizadeh","year":"2020","journal-title":"Biofactors."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jacl.2018.07.008","article-title":"Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia","volume":"12","author":"P\u00e9terfy","year":"2018","journal-title":"J Clin Lipidol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cca.2014.08.022","article-title":"Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency","volume":"438","author":"Okubo","year":"2015","journal-title":"Clin Chim Acta."},{"key":"B8","doi-asserted-by":"publisher","first-page":"105559","DOI":"10.1016\/j.tvjl.2020.105559","article-title":"Sequence analysis of the coding regions of the apolipoprotein C2 (APOC2) gene in Miniature Schnauzers with idiopathic hypertriglyceridemia","volume":"265","author":"Xenoulis","year":"2020","journal-title":"Vet J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.atherosclerosis.2018.06.161","article-title":"Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society","volume":"12","author":"Ariza","year":"2018","journal-title":"J Clin Lipidol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jacl.2018.05.014","article-title":"Co-occurrence of heterozygous CREB3L3 and APOA5 nonsense variants and polygenic risk in a patient with severe hypertriglyceridemia exacerbated by estrogen administration","volume":"12","author":"W\u00f3jcik","year":"2018","journal-title":"J Clin Lipidol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12944-019-1012-9","article-title":"Identification of a novel and heterozygous LMF1 nonsense mutation in an acute pancreatitis patient with severe hypertriglyceridemia, severe obesity and heavy smoking","volume":"18","author":"Chen","year":"2019","journal-title":"Lipids Health Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jacl.2018.06.018","article-title":"New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia","volume":"12","author":"Serveaux Dancer","year":"2018","journal-title":"J Clin Lipidol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.02.020","article-title":"A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: a series of cases","volume":"322","author":"Lima","year":"2021","journal-title":"Atherosclerosis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jacl.2018.01.011","article-title":"A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome","volume":"12","author":"Paquette","year":"2018","journal-title":"J Clin Lipidol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7344","DOI":"10.1074\/jbc.M211932200","article-title":"Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1","volume":"278","author":"Ioka","year":"2003","journal-title":"J Biol Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1001025","DOI":"10.1371\/journal.pcbi.1001025","article-title":"Identifying a high fraction of the human genome to be under selective constraint using GERP++","volume":"6","author":"Davydov","year":"2010","journal-title":"PLoS Comput Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"European Atherosclerosis Society Consensus Panel. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacl.2014.08.010","article-title":"Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1","volume":"8","author":"Ahmad","year":"2014","journal-title":"J Clin Lipidol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.6065\/apem.2017.22.1.68","article-title":"A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis","volume":"22","author":"Jung","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1399-0004.2009.01369.x","article-title":"Pink-creamy whole blood in a 3-month-old infant with a homozygous deletion in the lipoprotein lipase gene","volume":"77","author":"Avis","year":"2010","journal-title":"Clin Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.atherosclerosissup.2012.10.020","article-title":"A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment","volume":"14","author":"Stefanutti","year":"2013","journal-title":"Atheroscler Suppl."},{"key":"B23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacl.2014.10.003","article-title":"A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene","volume":"9","author":"Buonuomo","year":"2015","journal-title":"J Clin Lipidol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/08850666211054365","article-title":"Hypertriglyceridemia Induced Pancreatitis: plasmapheresis or conservative management?","volume":"3","author":"Dichtwald","year":"2021","journal-title":"J Intensive Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jca.21954","article-title":"Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis","volume":"37","author":"Chen","year":"2021","journal-title":"J Clin Apher."},{"key":"B26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ejim.2014.08.008","article-title":"Current knowledge of hypertriglyceridemic pancreatitis","volume":"25","author":"Valdivielso","year":"2014","journal-title":"Eur J Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MOL.0000000000000297","article-title":"Role of lipoprotein lipase in lipid metabolism","volume":"27","author":"Olivecrona","year":"2016","journal-title":"Curr Opin Lipidol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jacl.2020.11.007","article-title":"Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia","volume":"15","author":"Gill","year":"2021","journal-title":"J Clin Lipidol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"640859","DOI":"10.3389\/fgene.2021.640859","article-title":"Digenic Inheritance and Gene-Environment Interaction in a Patient With Hypertriglyceridemia and Acute Pancreatitis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1194\/jlr.ILR120000735","article-title":"GPIHBP1, a partner protein for lipoprotein lipase, is expressed only in capillary endothelial cells","volume":"61","author":"Meng","year":"2020","journal-title":"J Lipid Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2019.05.023","article-title":"GPIHBP1 and lipoprotein lipase, partners in plasma triglyceride metabolism","volume":"30","author":"Young","year":"2019","journal-title":"Cell Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2018.09.020","article-title":"Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism","volume":"487","author":"Liu","year":"2018","journal-title":"Clin Chim Acta."},{"key":"B35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jacl.2016.03.009","article-title":"Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene","volume":"10","author":"Rabacchi","year":"2016","journal-title":"J Clin Lipidol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1194\/jlr.M083832","article-title":"Impaired thermogenesis and sharp increases in plasma triglyceride levels in GPIHBP1-deficient mice during cold exposure","volume":"59","author":"Larsson","year":"2018","journal-title":"J Lipid Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0205858","DOI":"10.1371\/journal.pone.0205858","article-title":"Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance","volume":"13","author":"Surendran","year":"2018","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1194\/jlr.M076943","article-title":"Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding","volume":"58","author":"Allan","year":"2017","journal-title":"J Lipid Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1073\/pnas.1817984116","article-title":"Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis","volume":"116","author":"Birrane","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"19735","DOI":"10.1074\/jbc.M111.242024","article-title":"Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase","volume":"286","author":"Beigneux","year":"2011","journal-title":"J Biol Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1476-511X-6-23","article-title":"Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650)","volume":"6","author":"Wang","year":"2007","journal-title":"Lipids Health Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jacl.2015.09.007","article-title":"Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis","volume":"10","author":"Ariza","year":"2016","journal-title":"J Clin Lipidol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.792574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:00:30Z","timestamp":1646913630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.792574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":43,"alternative-id":["10.3389\/fped.2022.792574"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.792574","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"792574"}}